Literature DB >> 25974082

Hepatitis C virus gene sequencing as a tool for precise genotyping in the era of new direct antiviral agents.

Francesca Ceccherini Silberstein1, Velia Chiara Di Maio1, Marianna Aragri1, Marco Ciotti2, Valeria Cento1, Carlo Federico Perno1,2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25974082     DOI： 10.1002/hep.27895

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

1.  Hepatitis C virus subtyping in Uttarakhand, India: a comparative study.

Authors:  Kuhu Chatterjee; Deepjyoti Kalita; Balram Ji Omar; Rohit Gupta; Mithilesh Kumar Jha; Pratima Gupta
Journal:  Virusdisease       Date:  2021-08-17

2.  The cobas® HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice.

Authors:  J A Fernández-Caballero; M Alvarez; N Chueca; A B Pérez; F García
Journal:  PLoS One       Date:  2017-04-14       Impact factor: 3.240

3.  Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay.

Authors:  V Saludes; A Antuori; B Reinhardt; I Viciana; E Clavijo; L Schreiber; M Tenenbaum; F Rodriguez-Frias; J Quer; L Matas; E Martró
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

4.  Geographic Distribution of HCV-GT3 Subtypes and Naturally Occurring Resistance Associated Substitutions.

Authors:  Sabrina Bagaglio; Emanuela Messina; Hamid Hasson; Andrea Galli; Caterina Uberti-Foppa; Giulia Morsica
Journal:  Viruses       Date:  2019-02-11       Impact factor: 5.048

5.  Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms.

Authors:  Natalia Chueca; Isidro Rivadulla; Rubén Lovatti; Gabriel Reina; Ana Blanco; Jose Angel Fernandez-Caballero; Laura Cardeñoso; Javier Rodriguez-Granjer; Miriam Fernandez-Alonso; Antonio Aguilera; Marta Alvarez; Juan Carlos Galán; Federico García
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

6.  Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district.

Authors:  Ennio Polilli; Valeria Cento; Umberto Restelli; Francesca Ceccherini-Silberstein; Marianna Aragri; Velia Chiara Di Maio; Antonina Sciacca; Fiorenzo Santoleri; Paolo Fazii; Alberto Costantini; Carlo Federico Perno; Giustino Parruti
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-14

7.  Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis.

Authors:  Lize Cuypers; Ana Belén Pérez; Natalia Chueca; Teresa Aldamiz-Echevarría; Juan Carlos Alados; Ana María Martínez-Sapiña; Dolores Merino; Juan Antonio Pineda; Francisco Téllez; Nuria Espinosa; Javier Salméron; Antonio Rivero-Juarez; María Jesús Vivancos; Víctor Hontañón; Anne-Mieke Vandamme; Féderico García
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.